Preoperative Dose of Co-amoxiclav for Prevention of Postoperative Complications in Dentoalveolar Surgery
A Comparison of Single Preoperative Dose of Co-amoxiclav Versus Postoperative Full Course of Amoxicillin/ Co-amoxiclav in Prevention of Postoperative Complications in Dentoalveolar Surgery: a Randomized Controlled Trial
1 other identifier
interventional
135
1 country
1
Brief Summary
There was no evidence to judge the effects of preventative antibiotics for extractions of severely decayed teeth, teeth in diseased gums, or extractions in patients who are sick or have low immunity to infection. Undertaking research in these groups of people may not be possible or ethical. However, it is likely that in situations where patients are at a higher risk of infection that preventative antibiotics may be beneficial, because infections in this group are likely to be more frequent and more difficult to treat To the best of knowledge, no adult study has compared the effects of single dose of Co-Amoxiclave and full oral course before or after dentoalveolar surgery. The current study has formally considered this comparison as a potential valuable trail for reducing the postoperative complications in adult patients who have had surgical removal of teeth under LA.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 11, 2019
CompletedFirst Posted
Study publicly available on registry
February 18, 2019
CompletedStudy Start
First participant enrolled
October 2, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 2, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 20, 2021
CompletedOctober 6, 2020
October 1, 2020
1.2 years
February 11, 2019
October 5, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
infection rate
dry socket after surgical extraction
5 days after extraction assessment
Study Arms (3)
Co-Amoxiclav postoperatively alone
ACTIVE COMPARATOR• Treatment 1: 0.9% normal saline irrigation immediately after the surgery with course of Co-Amoxiclav 625 mg 0.2% chlorhexidine mouthwash following the surgery for 5 days (control group)
Co-Amoxiclav preoperatively with Metronidazole postoperatively
ACTIVE COMPARATOR• Treatment 2: 625 mg Co-Amoxiclav and 1g Paracetamol preoperatively and 0.2% chlorhexidine mouthwash immediately before the surgery with course of Metronidazole 500 mg and 0.2% chlorhexidine mouthwash following the surgery for 5 days
Co-Amoxiclav preoperatively with amoxicillin postoperatively
ACTIVE COMPARATOR• Treatment 3: 625 mg Co-Amoxiclav and 1g Paracetamol preoperatively and 0.2% chlorhexidine mouthwash immediately before the surgery with course of amoxicillin 500 mg and 0.2% chlorhexidine mouthwash following the surgery for 5 days
Interventions
amoxicillin + clavulanic acid orally
paracetamol orally
0.2% chlorhexidine mouthwash
0.9% normal saline irrigation
Amoxicillin 500 orally
metronidazole 500 mg orally
Eligibility Criteria
You may qualify if:
- Patient age from 16 to 70 yrs old
- Patient needs surgical teeth extraction (subject tooth will be removed using osteotomy by motorised drill).
You may not qualify if:
- Patients refusing the preoperative dose of oral co-amoxiclav, and unwilling to take part .
- Patients who are allergic to co-amoxiclve, amoxicillin or metronidazole
- Patient are on warfarin medication
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Taibah University
Madinah, 41311, Saudi Arabia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
February 11, 2019
First Posted
February 18, 2019
Study Start
October 2, 2019
Primary Completion
December 2, 2020
Study Completion
January 20, 2021
Last Updated
October 6, 2020
Record last verified: 2020-10
Data Sharing
- IPD Sharing
- Will share